Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.

Edwards, CM; Edwards, JR; Lwin, ST; Esparza, J; Oyajobi, BO; McCluskey, B; Munoz, S; Grubbs, B; Mundy, GR

Abstract:

There is increasing evidence to suggest that the Wnt signaling pathway plays a critical role in the pathogenesis of myeloma bone disease. In the present study, we determined whether increasing Wnt signaling within the bone marrow microenvironment in myeloma counteracts development of osteolytic bone disease. C57BL/KaLwRij mice were inoculated intravenously with murine 5TGM1 myeloma cells, resulting in tumor growth in bone and development of myeloma bone disease. Lithium chloride (LiCl) treatm...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Edwards, C. M., Edwards, J. R., Lwin, S. T., Esparza, J., Oyajobi, B. O., McCluskey, B., Munoz, S., Grubbs, B., & Mundy, G. R. (2008). Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo. Blood, 111(5), 2833–2842.

MLA Style

Edwards, C. M., et al. “Increasing Wnt Signaling in the Bone Marrow Microenvironment Inhibits the Development of Myeloma Bone Disease and Reduces Tumor Burden in Bone in Vivo.” Blood, vol. 111, no. 5, 2008, pp. 2833–42.

Chicago Style

Edwards, CM, JR Edwards, ST Lwin, J Esparza, BO Oyajobi, B McCluskey, S Munoz, B Grubbs, and GR Mundy. 2008. “Increasing Wnt Signaling in the Bone Marrow Microenvironment Inhibits the Development of Myeloma Bone Disease and Reduces Tumor Burden in Bone in Vivo.” Blood 111 (5): 2833–42.
Tweet
Print